ArticlePloS one2025

Retraction: Cardiovascular and mortality outcomes of DPP-4 inhibitors vs. sulfonylureas as metformin add-on therapy in patients with type 2 diabetes: A systematic review and meta-analysis.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.